my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Ablynx announced that Boehringer Ingelheim has submitted a Clinical Trials Application (CTA) to the European regulatory authorities to start a Phase I clinical trial with a Nanobody® for the treatment of Alzheimer's disease. The Nanobody has been developed as part of the collaboration signed betwee more
Galapagos NV announced that it has identified a pre-clinical compound in its alliance with Janssen Pharmaceutica NV. This achievement triggered a milestone payment of €6.6 million to Galapagos. The pre-clinical candidate was developed by Galapagos against a novel target discovered with Galapagos' p more
Genmab A/S announced it had reached the second pre-clinical milestone in the collaboration with H. Lundbeck A/S, triggering a €1 million payment. Genmab has reached the second milestone in the collaboration with H. Lundbeck A/S to create and develop human antibody therapeutics for disorders of the c more
Introduction GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - February 2012” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The repor more
Introduction GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2011” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The r more
Introduction GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for March 2012 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The repor more
home • contacts • sitemap • search About Company Overview Company History Leadership Team Board of Directors Company Values Careers Products Development Pipeline Partnered Programmes Marketed Products Product Supplies Business Development Partnering Business Development Contacts Investors Share Pric more
A A Home About Us Investors Management Board of Directors Scientific Advisory Board Technologies Antibodies Overview Intellectual Property Glossary Partnering Press Room Career Contact Maps & Directions Basel Site Maps & Directions Jena Site Press Room Recent news releases March 16, 2010: 4-Antibody more
Watchlist
This is where you can add this topic to your personal favourites
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2012 CHEMIE.DE Information Service GmbH, All rights reserved
